NIH-funded research R01 grant

How PFAS chemicals may increase the risk of preterm birth due to infections

Official title: PFAS increases susceptibility to infection-mediated PTB

Funded at Wayne State University · NIH-10768105 · Data updated 2026-11-12

This study is looking at how exposure to certain chemicals called PFAS might affect pregnant women by weakening the placenta's ability to fight infections, which could lead to preterm birth, and it aims to help identify pregnancies that might be at risk.

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionWayne State University
NIH-funded
Lab location1 site (Detroit, United States)
Project startSeptember 5, 2024
Project endJune 30, 2029
Funding year2024
Award (this year)$533,723
NIH project number1R01ES035692-01A1
Project IDNIH-10768105 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research include pregnant individuals exposed to PFAS and at risk for preterm birth due to infections.

Less likely to help

Patients who are not pregnant or those not exposed to PFAS may not benefit from this research.

What this research studies

This research investigates the link between exposure to PFAS chemicals and the risk of preterm birth (PTB) caused by infections. It focuses on how PFAS can weaken the immune response in the placenta, which is crucial for protecting against infections that could lead to PTB. By studying the mechanisms of how PFAS affect interferon signaling in the placenta, the research aims to uncover why some maternal infections result in PTB while others do not. The findings could help identify at-risk pregnancies and inform preventive strategies.

Why it matters

Potential benefit: If successful, this research could lead to improved understanding and prevention of preterm births associated with infections, ultimately enhancing maternal and infant health.

How similar studies have gone: Previous research has shown that environmental pollutants like PFAS can negatively impact immune function, suggesting that this study's approach is grounded in established findings.

Where this research is happening

  • Wayne State University
    Detroit, United States
    Active

Researchers

  • Principal investigator: Petriello, Michael Curtis — Wayne State University
  • Study coordinator: Petriello, Michael Curtis

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.